These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32287579)

  • 21. Polio returns to the USA: An epidemiological alert.
    Rai A; Uwishema O; Uweis L; El Saleh R; Arab S; Abbass M; Wellington J; Musabirema F; Adanur I; Patrick Onyeaka CV
    Ann Med Surg (Lond); 2022 Oct; 82():104563. PubMed ID: 36268372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel gamma radiation-inactivated sabin-based polio vaccine.
    Tobin GJ; Tobin JK; Gaidamakova EK; Wiggins TJ; Bushnell RV; Lee WM; Matrosova VY; Dollery SJ; Meeks HN; Kouiavskaia D; Chumakov K; Daly MJ
    PLoS One; 2020; 15(1):e0228006. PubMed ID: 31999745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Picornavirus and enterovirus diversity with associated human diseases.
    Tapparel C; Siegrist F; Petty TJ; Kaiser L
    Infect Genet Evol; 2013 Mar; 14():282-93. PubMed ID: 23201849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationalizing the development of live attenuated virus vaccines.
    Lauring AS; Jones JO; Andino R
    Nat Biotechnol; 2010 Jun; 28(6):573-9. PubMed ID: 20531338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic diversity of type 1 polioviruses and its implications for the efficacy of polio vaccines.
    Kouiavskaia D; Mirochnitchenko O; Troy S; Chumakov K
    Vaccine; 2023 Mar; 41(13):2147-2154. PubMed ID: 36828716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
    Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
    Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.
    Stone JK; Rijnbrand R; Stein DA; Ma Y; Yang Y; Iversen PL; Andino R
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1970-81. PubMed ID: 18347107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis and treatment of influenza virus infection.
    Kandel R; Hartshorn KL
    BioDrugs; 2001; 15(5):303-23. PubMed ID: 11437694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of broad-spectrum enterovirus antivirals based on quinoline scaffold.
    Musharrafieh R; Kitamura N; Hu Y; Wang J
    Bioorg Chem; 2020 Aug; 101():103981. PubMed ID: 32559580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game.
    van der Sanden SM; Wu W; Dybdahl-Sissoko N; Weldon WC; Brooks P; O'Donnell J; Jones LP; Brown C; Tompkins SM; Oberste MS; Karpilow J; Tripp RA
    J Virol; 2016 Feb; 90(4):1694-704. PubMed ID: 26581994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. sIPV process development for costs reduction.
    Thomassen YE; Bakker WA
    Vaccine; 2015 Aug; 33(35):4307-12. PubMed ID: 25858858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of enterovirus-specific cellular immunity in two populations of young children vaccinated with inactivated or live poliovirus vaccines.
    Juhela S; Hyöty H; Uibo R; Meriste SH; Uibo O; Lönnrot M; Halminen M; Simell O; Ilonen J
    Clin Exp Immunol; 1999 Jul; 117(1):100-5. PubMed ID: 10403922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Fight against Poliovirus Is Not Over.
    Mbani CJ; Nekoua MP; Moukassa D; Hober D
    Microorganisms; 2023 May; 11(5):. PubMed ID: 37317297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it?
    Bull JJ
    Virus Evol; 2015 Jan; 1(1):. PubMed ID: 27034780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of respiratory picornaviruses with acute bronchiolitis in French infants.
    Jacques J; Bouscambert-Duchamp M; Moret H; Carquin J; Brodard V; Lina B; Motte J; Andréoletti L
    J Clin Virol; 2006 Apr; 35(4):463-6. PubMed ID: 16406692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
    Ramsay ME; Begg NT; Gandhi J; Brown D
    Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Antiviral Activity of
    Choi HJ
    Osong Public Health Res Perspect; 2016 Dec; 7(6):400-403. PubMed ID: 28053847
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.